SEC 13F Intelligence

Boxer Capital, LLC / AXSM

Boxer Capital, LLC’s Axsome Therapeutics Inc. Position

Does Boxer Capital, LLC own Axsome Therapeutics Inc. (AXSM)? Not currently — the last reported position was 400.0K shares worth $36M in Q3 2024; the fund’s latest 13F (Q4 2024) no longer reports it.

Position Value
$36M
Q3 2024
Shares
400.0K
% of Portfolio
+1.76%
Quarters Held
9
position exited

Position History AXSM

Reported value by quarter
Q1 ’20: $9MQ1 ’20Q4 ’22: $31MQ1 ’23: $24,672Q1 ’23Q2 ’23: $28,744Q3 ’23: $28MQ3 ’23Q4 ’23: $32MQ1 ’24: $32MQ1 ’24Q2 ’24: $32MQ3 ’24: $36MQ3 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2024400.0K$36M+1.76%
Q2 2024400.0K$32M+1.70%
Q1 2024400.0K$32M+1.58%
Q4 2023400.0K$32M+1.59%
Q3 2023400.0K$28M+1.49%
Q2 2023400.0K$28,744+1.33%
Q1 2023400.0K$24,672+1.21%
Q4 2022400.0K$31M+1.63%
Q1 2020150.0K$9M+0.60%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital, LLC’s full portfolio or all institutional holders of AXSM.